Loading…
Cost-effectiveness of Using Quantiferon Gold (QFT-G)® versus Tuberculin Skin Test (TST) among U.S. and Foreign Born Populations at a Public Health Department Clinic with a Low Prevalence of Tuberculosis
Objective The purpose of this study was to determine the cost benefit to routinely using QFT‐G versus the standard TST for screening U.S. and foreign born populations at a public health department clinic with a low prevalence of tuberculosis. Design and Sample A comparative cost analysis of the mone...
Saved in:
Published in: | Public health Nursing 2014-03, Vol.31 (2), p.144-152 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4243-a63d9d629cef06adbae86ec788a348c2ad6b10dcdc4136f6ba97ca01d79c25513 |
---|---|
cites | cdi_FETCH-LOGICAL-c4243-a63d9d629cef06adbae86ec788a348c2ad6b10dcdc4136f6ba97ca01d79c25513 |
container_end_page | 152 |
container_issue | 2 |
container_start_page | 144 |
container_title | Public health Nursing |
container_volume | 31 |
creator | Iqbal, Ayesha Z. Leighton, Jenelle Anthony, John Knaup, Richard C. Peters, Eleanor B. Bailey, Thomas C. |
description | Objective
The purpose of this study was to determine the cost benefit to routinely using QFT‐G versus the standard TST for screening U.S. and foreign born populations at a public health department clinic with a low prevalence of tuberculosis.
Design and Sample
A comparative cost analysis of the monetization between QFT‐G and TST was conducted: Data from the health department's Chest Clinic patients seen in 2007 were used to model cost predictions.
Measures
The net costs of screening, x‐rays, the standard 9 months of latent tuberculosis infection treatment, laboratory, and administration for U.S. born patients and foreign born patients were investigated.
Results
There are no apparent cost savings for U.S. born individuals, but due to the higher specificity of QFT‐G for foreign born BCG‐vaccinated individuals, there are unnecessary expenditures associated with the higher number of false positives incurred when using TST compared with QFT‐G on 1,000 foreign born individuals (69%, 18%).
Conclusion
QFT‐G is cost‐effective and should be used at local health department clinics that want to achieve savings in screening and treating those suspected of having TB infection, especially for high‐risk populations such as foreign born individuals. |
doi_str_mv | 10.1111/phn.12083 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1523398951</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3250396141</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4243-a63d9d629cef06adbae86ec788a348c2ad6b10dcdc4136f6ba97ca01d79c25513</originalsourceid><addsrcrecordid>eNqNks9uEzEQxlcIREvhwAugkbgkh03t9f490kASUFRSZQNHy-udbd1u7GDvJvSleAiuvBQOaXpAQmIOHsnzm08zmi8IXlMyoj7ONzd6RCOSsyfBKU2iJKRxnD4NTknGstAXipPghXO3hBCWROnz4CSKKc1ylp0Gv8bGdSE2DcpObVGjc2AaWDmlr-GqF7pTDVqjYWraGgZXkzKcDn_-gC1a1zso-wqt7FulYXnnnxJdB4NyWQ5BrI2XWI2WIxC6homxqK41XBirYWE2fSs6ZbQD0YGARV-1SsIMRdvdwHvcCNutUXcw9tK-sFP-W8Dc7GBhcSta1BL3gx4HME65l8GzRrQOXz3ks2A1-VCOZ-H88_Tj-N08lHEUs1CkrC7qNCokNiQVdSUwT1FmeS5YnMtI1GlFSS1rGVOWNmklikwKQuuskFGSUHYWDA66G2u-9X5jvlZOYtsKjaZ33J-AsSIv_gslcZyQqCg8-vYv9Nb0VvtF9lSeZFGcJJ4aHihpjXMWG76xai3sPaeE783AvRn4HzN49s2DYl-tsX4kj9f3wPkB2KkW7_-txBezy6NkeOhQrsPvjx3C3vHUmy3hXy-nfPlpln6ZLAkv2G-WiM6M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1508572455</pqid></control><display><type>article</type><title>Cost-effectiveness of Using Quantiferon Gold (QFT-G)® versus Tuberculin Skin Test (TST) among U.S. and Foreign Born Populations at a Public Health Department Clinic with a Low Prevalence of Tuberculosis</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><creator>Iqbal, Ayesha Z. ; Leighton, Jenelle ; Anthony, John ; Knaup, Richard C. ; Peters, Eleanor B. ; Bailey, Thomas C.</creator><creatorcontrib>Iqbal, Ayesha Z. ; Leighton, Jenelle ; Anthony, John ; Knaup, Richard C. ; Peters, Eleanor B. ; Bailey, Thomas C.</creatorcontrib><description>Objective
The purpose of this study was to determine the cost benefit to routinely using QFT‐G versus the standard TST for screening U.S. and foreign born populations at a public health department clinic with a low prevalence of tuberculosis.
Design and Sample
A comparative cost analysis of the monetization between QFT‐G and TST was conducted: Data from the health department's Chest Clinic patients seen in 2007 were used to model cost predictions.
Measures
The net costs of screening, x‐rays, the standard 9 months of latent tuberculosis infection treatment, laboratory, and administration for U.S. born patients and foreign born patients were investigated.
Results
There are no apparent cost savings for U.S. born individuals, but due to the higher specificity of QFT‐G for foreign born BCG‐vaccinated individuals, there are unnecessary expenditures associated with the higher number of false positives incurred when using TST compared with QFT‐G on 1,000 foreign born individuals (69%, 18%).
Conclusion
QFT‐G is cost‐effective and should be used at local health department clinics that want to achieve savings in screening and treating those suspected of having TB infection, especially for high‐risk populations such as foreign born individuals.</description><identifier>ISSN: 0737-1209</identifier><identifier>EISSN: 1525-1446</identifier><identifier>DOI: 10.1111/phn.12083</identifier><identifier>PMID: 24117837</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Adolescent ; Adult ; Comparative analysis ; Cost-Benefit Analysis ; Cost-effectiveness ; Emigration and Immigration - statistics & numerical data ; Female ; Health care expenditures ; Humans ; LTBI ; Male ; Medical screening ; Middle Aged ; Nursing ; Prevalence ; Public health ; Public Health - economics ; screening ; Sensitivity and Specificity ; TST ; Tuberculin Test - economics ; Tuberculin Test - methods ; Tuberculosis ; Tuberculosis - diagnosis ; Tuberculosis - epidemiology ; United States - epidemiology ; Young Adult</subject><ispartof>Public health Nursing, 2014-03, Vol.31 (2), p.144-152</ispartof><rights>2013 Wiley Periodicals, Inc.</rights><rights>Copyright Blackwell Publishing Ltd. Mar/Apr 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4243-a63d9d629cef06adbae86ec788a348c2ad6b10dcdc4136f6ba97ca01d79c25513</citedby><cites>FETCH-LOGICAL-c4243-a63d9d629cef06adbae86ec788a348c2ad6b10dcdc4136f6ba97ca01d79c25513</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24117837$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Iqbal, Ayesha Z.</creatorcontrib><creatorcontrib>Leighton, Jenelle</creatorcontrib><creatorcontrib>Anthony, John</creatorcontrib><creatorcontrib>Knaup, Richard C.</creatorcontrib><creatorcontrib>Peters, Eleanor B.</creatorcontrib><creatorcontrib>Bailey, Thomas C.</creatorcontrib><title>Cost-effectiveness of Using Quantiferon Gold (QFT-G)® versus Tuberculin Skin Test (TST) among U.S. and Foreign Born Populations at a Public Health Department Clinic with a Low Prevalence of Tuberculosis</title><title>Public health Nursing</title><addtitle>Public Health Nurs</addtitle><description>Objective
The purpose of this study was to determine the cost benefit to routinely using QFT‐G versus the standard TST for screening U.S. and foreign born populations at a public health department clinic with a low prevalence of tuberculosis.
Design and Sample
A comparative cost analysis of the monetization between QFT‐G and TST was conducted: Data from the health department's Chest Clinic patients seen in 2007 were used to model cost predictions.
Measures
The net costs of screening, x‐rays, the standard 9 months of latent tuberculosis infection treatment, laboratory, and administration for U.S. born patients and foreign born patients were investigated.
Results
There are no apparent cost savings for U.S. born individuals, but due to the higher specificity of QFT‐G for foreign born BCG‐vaccinated individuals, there are unnecessary expenditures associated with the higher number of false positives incurred when using TST compared with QFT‐G on 1,000 foreign born individuals (69%, 18%).
Conclusion
QFT‐G is cost‐effective and should be used at local health department clinics that want to achieve savings in screening and treating those suspected of having TB infection, especially for high‐risk populations such as foreign born individuals.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Comparative analysis</subject><subject>Cost-Benefit Analysis</subject><subject>Cost-effectiveness</subject><subject>Emigration and Immigration - statistics & numerical data</subject><subject>Female</subject><subject>Health care expenditures</subject><subject>Humans</subject><subject>LTBI</subject><subject>Male</subject><subject>Medical screening</subject><subject>Middle Aged</subject><subject>Nursing</subject><subject>Prevalence</subject><subject>Public health</subject><subject>Public Health - economics</subject><subject>screening</subject><subject>Sensitivity and Specificity</subject><subject>TST</subject><subject>Tuberculin Test - economics</subject><subject>Tuberculin Test - methods</subject><subject>Tuberculosis</subject><subject>Tuberculosis - diagnosis</subject><subject>Tuberculosis - epidemiology</subject><subject>United States - epidemiology</subject><subject>Young Adult</subject><issn>0737-1209</issn><issn>1525-1446</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqNks9uEzEQxlcIREvhwAugkbgkh03t9f490kASUFRSZQNHy-udbd1u7GDvJvSleAiuvBQOaXpAQmIOHsnzm08zmi8IXlMyoj7ONzd6RCOSsyfBKU2iJKRxnD4NTknGstAXipPghXO3hBCWROnz4CSKKc1ylp0Gv8bGdSE2DcpObVGjc2AaWDmlr-GqF7pTDVqjYWraGgZXkzKcDn_-gC1a1zso-wqt7FulYXnnnxJdB4NyWQ5BrI2XWI2WIxC6homxqK41XBirYWE2fSs6ZbQD0YGARV-1SsIMRdvdwHvcCNutUXcw9tK-sFP-W8Dc7GBhcSta1BL3gx4HME65l8GzRrQOXz3ks2A1-VCOZ-H88_Tj-N08lHEUs1CkrC7qNCokNiQVdSUwT1FmeS5YnMtI1GlFSS1rGVOWNmklikwKQuuskFGSUHYWDA66G2u-9X5jvlZOYtsKjaZ33J-AsSIv_gslcZyQqCg8-vYv9Nb0VvtF9lSeZFGcJJ4aHihpjXMWG76xai3sPaeE783AvRn4HzN49s2DYl-tsX4kj9f3wPkB2KkW7_-txBezy6NkeOhQrsPvjx3C3vHUmy3hXy-nfPlpln6ZLAkv2G-WiM6M</recordid><startdate>201403</startdate><enddate>201403</enddate><creator>Iqbal, Ayesha Z.</creator><creator>Leighton, Jenelle</creator><creator>Anthony, John</creator><creator>Knaup, Richard C.</creator><creator>Peters, Eleanor B.</creator><creator>Bailey, Thomas C.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7TS</scope><scope>ASE</scope><scope>C1K</scope><scope>FPQ</scope><scope>K6X</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>201403</creationdate><title>Cost-effectiveness of Using Quantiferon Gold (QFT-G)® versus Tuberculin Skin Test (TST) among U.S. and Foreign Born Populations at a Public Health Department Clinic with a Low Prevalence of Tuberculosis</title><author>Iqbal, Ayesha Z. ; Leighton, Jenelle ; Anthony, John ; Knaup, Richard C. ; Peters, Eleanor B. ; Bailey, Thomas C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4243-a63d9d629cef06adbae86ec788a348c2ad6b10dcdc4136f6ba97ca01d79c25513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Comparative analysis</topic><topic>Cost-Benefit Analysis</topic><topic>Cost-effectiveness</topic><topic>Emigration and Immigration - statistics & numerical data</topic><topic>Female</topic><topic>Health care expenditures</topic><topic>Humans</topic><topic>LTBI</topic><topic>Male</topic><topic>Medical screening</topic><topic>Middle Aged</topic><topic>Nursing</topic><topic>Prevalence</topic><topic>Public health</topic><topic>Public Health - economics</topic><topic>screening</topic><topic>Sensitivity and Specificity</topic><topic>TST</topic><topic>Tuberculin Test - economics</topic><topic>Tuberculin Test - methods</topic><topic>Tuberculosis</topic><topic>Tuberculosis - diagnosis</topic><topic>Tuberculosis - epidemiology</topic><topic>United States - epidemiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iqbal, Ayesha Z.</creatorcontrib><creatorcontrib>Leighton, Jenelle</creatorcontrib><creatorcontrib>Anthony, John</creatorcontrib><creatorcontrib>Knaup, Richard C.</creatorcontrib><creatorcontrib>Peters, Eleanor B.</creatorcontrib><creatorcontrib>Bailey, Thomas C.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Physical Education Index</collection><collection>British Nursing Index</collection><collection>Environmental Sciences and Pollution Management</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Public health Nursing</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iqbal, Ayesha Z.</au><au>Leighton, Jenelle</au><au>Anthony, John</au><au>Knaup, Richard C.</au><au>Peters, Eleanor B.</au><au>Bailey, Thomas C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cost-effectiveness of Using Quantiferon Gold (QFT-G)® versus Tuberculin Skin Test (TST) among U.S. and Foreign Born Populations at a Public Health Department Clinic with a Low Prevalence of Tuberculosis</atitle><jtitle>Public health Nursing</jtitle><addtitle>Public Health Nurs</addtitle><date>2014-03</date><risdate>2014</risdate><volume>31</volume><issue>2</issue><spage>144</spage><epage>152</epage><pages>144-152</pages><issn>0737-1209</issn><eissn>1525-1446</eissn><abstract>Objective
The purpose of this study was to determine the cost benefit to routinely using QFT‐G versus the standard TST for screening U.S. and foreign born populations at a public health department clinic with a low prevalence of tuberculosis.
Design and Sample
A comparative cost analysis of the monetization between QFT‐G and TST was conducted: Data from the health department's Chest Clinic patients seen in 2007 were used to model cost predictions.
Measures
The net costs of screening, x‐rays, the standard 9 months of latent tuberculosis infection treatment, laboratory, and administration for U.S. born patients and foreign born patients were investigated.
Results
There are no apparent cost savings for U.S. born individuals, but due to the higher specificity of QFT‐G for foreign born BCG‐vaccinated individuals, there are unnecessary expenditures associated with the higher number of false positives incurred when using TST compared with QFT‐G on 1,000 foreign born individuals (69%, 18%).
Conclusion
QFT‐G is cost‐effective and should be used at local health department clinics that want to achieve savings in screening and treating those suspected of having TB infection, especially for high‐risk populations such as foreign born individuals.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>24117837</pmid><doi>10.1111/phn.12083</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0737-1209 |
ispartof | Public health Nursing, 2014-03, Vol.31 (2), p.144-152 |
issn | 0737-1209 1525-1446 |
language | eng |
recordid | cdi_proquest_miscellaneous_1523398951 |
source | Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list) |
subjects | Adolescent Adult Comparative analysis Cost-Benefit Analysis Cost-effectiveness Emigration and Immigration - statistics & numerical data Female Health care expenditures Humans LTBI Male Medical screening Middle Aged Nursing Prevalence Public health Public Health - economics screening Sensitivity and Specificity TST Tuberculin Test - economics Tuberculin Test - methods Tuberculosis Tuberculosis - diagnosis Tuberculosis - epidemiology United States - epidemiology Young Adult |
title | Cost-effectiveness of Using Quantiferon Gold (QFT-G)® versus Tuberculin Skin Test (TST) among U.S. and Foreign Born Populations at a Public Health Department Clinic with a Low Prevalence of Tuberculosis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T16%3A41%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cost-effectiveness%20of%20Using%20Quantiferon%20Gold%20(QFT-G)%C2%AE%20versus%20Tuberculin%20Skin%20Test%20(TST)%20among%20U.S.%20and%20Foreign%20Born%20Populations%20at%20a%20Public%20Health%20Department%20Clinic%20with%20a%20Low%20Prevalence%20of%20Tuberculosis&rft.jtitle=Public%20health%20Nursing&rft.au=Iqbal,%20Ayesha%20Z.&rft.date=2014-03&rft.volume=31&rft.issue=2&rft.spage=144&rft.epage=152&rft.pages=144-152&rft.issn=0737-1209&rft.eissn=1525-1446&rft_id=info:doi/10.1111/phn.12083&rft_dat=%3Cproquest_cross%3E3250396141%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4243-a63d9d629cef06adbae86ec788a348c2ad6b10dcdc4136f6ba97ca01d79c25513%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1508572455&rft_id=info:pmid/24117837&rfr_iscdi=true |